Anterior Wedge in Patients With Osteoarthritis Hip

Gait, Frontal Clinical Trial

Official title:

Effect of Anterior Wedge Use in Patients With Osteoarthritis Hip

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03393923
• Other study ID #: 1112131232234
• Status: Completed
• Phase: N/A
• Start date: July 10, 2017
• Est. completion date: December 10, 2018

Study information

• Verified date: January 2017
• Source: Faculdade de Ciências Médicas da Santa Casa de São Paulo
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Ostearthritis is a great source of pain. In symptomatic hip the pain can lead the major disability and poor quality of life. Understand the musculoskeletal factores can lead to a better clinical management. The muscle strenghening of posterolateral complexo of hip is a important consideration. General Objective: Perform a Kinetic analysis 2D using na anterior wedge. Specific objective: Analyze the influence of posterolateral hip complex. Controlled clinical trial, composed by 30 individuals with and without osteoarthritis of hip e will be used a tools; Analogic Visual Scale, manual dynamometry to analyze force and kinetic analyze of gait through of Myovídeo analysis software.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 18
• Est. completion date: December 10, 2018
• Est. primary completion date: January 1, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 50 Years to 75 Years

Eligibility

Inclusion Criteria:

• Sedentary individuals

• Both genders

• Age equal to or greather than 50 years

• Diagnosis of osteoarthritis level II and III

Exclusion Criteria:

• fractures

• Neuromuscular diseases

• Other diseases of hip

Related Conditions & MeSH terms

• Gait Disorders, Neurologic
• Gait, Frontal
• Osteoarthritis
• Osteoarthritis, Hip

Intervention

Other:
• Application of the anterior wedge
Application of anterior wedge in tennis

Locations

Country	Name	City	State
Brazil	Flávia Nakatake	São Paulo

Sponsors (1)

Lead Sponsor	Collaborator
Faculdade de Ciências Médicas da Santa Casa de São Paulo

Country where clinical trial is conducted

Brazil, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Inproved performance of the gluteus maximus	Extent moment will be assessed by gait analysis	24 hours